(ASND) Ascendis Pharma AS - Performance 4% in 12m
Compare ASND with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
2.69%
#36 in Group
Rel. Strength
49.23%
#3879 in Universe
Total Return 12m
4.00%
#38 in Group
Total Return 5y
28.58%
#36 in Group
P/E -
(unknown) Percentile in Group
P/E Forward -
(unknown) Percentile in Group
PEG -
(unknown) Percentile in Group
FCF Yield -3.45%
(unknown) Percentile in Group
12m Total Return: ASND (4%) vs XBI (-11%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: ASND vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ASND
Total Return (including Dividends) | ASND | XBI | S&P 500 |
---|---|---|---|
1 Month | 0.14% | -5.85% | -3.01% |
3 Months | 10.25% | -11.95% | -3.15% |
12 Months | 4.00% | -11.00% | 10.19% |
5 Years | 28.58% | 0.65% | 129.24% |
Trend Score (consistency of price movement) | ASND | XBI | S&P 500 |
1 Month | 32.1% | -59.8% | -5.5% |
3 Months | 72.2% | -70.5% | -58.4% |
12 Months | 12.4% | -6.9% | 84.1% |
5 Years | -26.3% | -50% | 84.4% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #52 | 6.36% | 3.25% |
3 Month | #27 | 25.2% | 13.8% |
12 Month | #39 | 16.9% | -5.61% |
5 Years | #37 | 27.8% | -43.9% |
FAQs
Does ASND Ascendis Pharma AS outperforms the market?
Yes,
over the last 12 months ASND made 4.00%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months ASND made 10.25%, while XBI made -11.95%.
Over the last 3 months ASND made 10.25%, while XBI made -11.95%.
Performance Comparison ASND vs Indeces and Sectors
ASND vs. Indices ASND is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -3.16% | 3.15% | 4.13% | -6.19% |
US NASDAQ 100 | QQQ | -2.18% | 4.20% | 4.90% | -4.60% |
US Dow Jones Industrial 30 | DIA | -3.36% | 2.28% | 3.21% | -5.51% |
German DAX 40 | DAX | -1.86% | 3.52% | -12.7% | -17.7% |
Shanghai Shenzhen CSI 300 | CSI 300 | -2.87% | -0.09% | 19.4% | -5.12% |
Hongkong Hang Seng | HSI | -5.13% | -2.63% | 13.4% | -13.3% |
India NIFTY 50 | INDA | -4.19% | -7.73% | 14.5% | 3.30% |
Brasil Bovespa | EWZ | -3.27% | -8.15% | 12.1% | 15.7% |
ASND vs. Sectors ASND is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -1.62% | 3.95% | -3.98% | -15.2% |
Consumer Discretionary | XLY | -3.92% | 3.97% | 0.77% | -10.1% |
Consumer Staples | XLP | -5.95% | 1.98% | 3.29% | -7.03% |
Energy | XLE | -4.25% | -7.88% | -1.45% | 3.19% |
Financial | XLF | -3.64% | 2.84% | -8.03% | -18.3% |
Health Care | XLV | -3.58% | 3.30% | 8.83% | 2.31% |
Industrial | XLI | -3.47% | 0.83% | 4.84% | -4.53% |
Materials | XLB | -4.26% | -0.37% | 12.2% | 7.94% |
Real Estate | XLRE | -5.20% | 2.83% | 7.25% | -9.36% |
Technology | XLK | -2.03% | 4.15% | 9.25% | 1.99% |
Utilities | XLU | -6.45% | -0.68% | 5.01% | -21.2% |
Aerospace & Defense | XAR | -2.56% | -1.14% | 0.21% | -16.9% |
Biotech | XBI | 1.40% | 5.99% | 21.8% | 15.0% |
Homebuilder | XHB | -3.66% | -0.01% | 23.5% | 11.7% |
Retail | XRT | -5.46% | 0.64% | 8.21% | 8.79% |